Elimination pathways of systemically delivered siRNA

Area of Science:

• Pharmacology and Drug Delivery
• Molecular Biology
• Hepatobiliary System Research

Background:

• Systemic administration of small interfering RNA (siRNA) necessitates understanding its elimination pathways for therapeutic efficacy.
• Current knowledge on siRNA excretion and biodistribution requires further elucidation, particularly concerning organ-specific accumulation and clearance.
• The role of delivery carriers in modulating siRNA fate remains a critical area for investigation in RNA therapeutics.

Purpose of the Study:

• To investigate the elimination process of systemically administered small interfering RNA (siRNA).
• To identify and characterize novel pathways involved in siRNA excretion.
• To evaluate the impact of delivery carriers on siRNA distribution and elimination.

Main Methods:

• Utilized infrared fluorescent dye-labeled small interfering RNA (siRNA) for tracking.
• Investigated siRNA distribution and accumulation in various organs following systemic administration.
• Examined the effect of blocking a specific elimination pathway on siRNA biodistribution.

Main Results:

• Identified a novel siRNA elimination pathway involving secretion from the liver into the gallbladder, followed by intestinal emptying.
• Blocking this pathway led to a complete absence of intestinal siRNA fluorescence.
• Simultaneously, blocking the pathway resulted in significantly enhanced siRNA accumulation within the liver and gallbladder.

Conclusions:

• A previously unrecognized hepatobiliary-intestinal pathway is critical for the elimination of systemically administered siRNA.
• Delivery carriers significantly influence the distribution and elimination kinetics of siRNA in vivo.
• Understanding and potentially modulating this pathway is essential for optimizing siRNA therapeutic strategies and delivery systems.